Xenon Pharmaceuticals XENE Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -4,974.3%— | —— | —— | -1,368.9%-940pp | |
| Net margin | -4,612.1%— | —— | —— | -1,328.9%-901pp | |
| EBITDA margin | -4,940.4%— | —— | —— | -1,354%-930pp | |
| Free cash flow margin | -3,732.2%— | —— | —— | -1,101.6%-713pp | |
| Returns | |||||
| Return on equity | -51.8%-23.9pp | -27.8%-5.7pp | -22.1%-2.4pp | -19.7%+2.1pp | |
| Return on assets | -48.3%-21.8pp | -26.6%-5.4pp | -21.2%-2.3pp | -18.9%+1.8pp | |
| Return on invested capital | -73.7%-34.2pp | -39.6%-10.4pp | -29.2%-4.8pp | -24.4%+6.4pp | |
| Efficiency | |||||
| Asset turnover | 0×— | 0×— | 0×0.0× | 0×0.0× | |
| Liquidity | |||||
| Current ratio | 13.4×-4.4× | 17.8×-5.8× | 23.6×-2.8× | 26.4×-12.6× | |
| Quick ratio | 13.4×-4.4× | 17.8×-5.8× | 23.6×-2.8× | 26.4×-12.6× | |
| Cash ratio | 4.8×+0.8× | 4×-1.4× | 5.5×+2.9× | 2.5×-9.7× | |
| Leverage | |||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Per Share | |||||
| Book value per share | $7.34-24.3% | $9.69-30.1% | $13.87+16.4% | $11.92-5.5% | |
| Valuation | |||||
| Market capitalization | $3.46B+15.9% | $2.99B-7.3% | $3.22B+30.7% | $2.47B+53.0% | |
| Enterprise value | $3.27B+14.6% | $2.85B-7.5% | $3.08B+27.5% | $2.42B+67.5% | |
| Price / sales | 461.8×— | —— | —— | 261.4×+174× | |
| Price / book | 6×+2.0× | 4×+0.5× | 3.5×+0.1× | 3.4×+0.5× | |
| EV / sales | 436.3×— | —— | —— | 256.4×+178× | |
| Free cash flow yield | -8.1%-1.9pp | -6.2%-1.3pp | -4.9%-0.6pp | -4.2%+0.2pp | |
| Earnings yield | -10%-2.1pp | -7.8%-2.2pp | -5.7%-0.6pp | -5.1%-0.2pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Xenon Pharmaceuticals's ratios come from?
- Every ratio is computed from Xenon Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.